Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systemic corticosteroids in asthma: A call to action from World Allergy Organization and Respiratory Effectiveness Group
Eugene R. Bleecker, Mona Al‐Ahmad, Leif Bjermer, et al.
World Allergy Organization Journal (2022) Vol. 15, Iss. 12, pp. 100726-100726
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Adverse consequences of systemic corticosteroids use among a broad population of US adults with asthma: a real-world analysis
Sandra Sze-jung Wu, Michelle Vu, Omar Motawakel, et al.
Journal of Medical Economics (2025), pp. 1-18
Open Access | Times Cited: 1
Safety of dupilumab in T2 airways conditions: focus on eosinophilia across trials and real-life evidence
Marco Caminati, Claudio Micheletto, Francesca Norelli, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 1-2, pp. 15-23
Closed Access | Times Cited: 7
Pediatric asthma comorbidities: Global impact and unmet needs
Elham Hossny, Yuichi Adachi, Eleni Anastasiou, et al.
World Allergy Organization Journal (2024) Vol. 17, Iss. 5, pp. 100909-100909
Open Access | Times Cited: 4
Comparative Effectiveness of Dupilumab and Omalizumab on Asthma Exacerbations and Systemic Corticosteroid Prescriptions: Real-World US ADVANTAGE Study
Eugene R. Bleecker, Michael S. Blaiss, Juby A. Jacob‐Nara, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 6, pp. 1500-1510
Open Access | Times Cited: 4
Experiences of Oral Corticosteroid Use and Adverse Effects: A National Cross-Sectional Survey of People with Asthma
Arwel W. Jones, Vanessa M. McDonald, Rebecca F. McLoughlin, et al.
Patient Preference and Adherence (2025) Vol. Volume 19, pp. 75-85
Open Access
Bispecific Domain Antibody Attenuates Airway Hyperresponsiveness and Pulmonary Inflammation in Ovalbumin-Lipopolysaccharide Induced Asthma Model by Inhibiting IL-23 and TNF-α
Chirag Ketan Gala, Sandeep Sherawat, Abhay H. Pande, et al.
Pulmonary Pharmacology & Therapeutics (2025), pp. 102347-102347
Closed Access
Predicting Risk of Morbidities Associated with Oral Corticosteroid Prescription for Asthma
Brooklyn Stanley, J. Chapaneri, Mina Khezrian, et al.
Pragmatic and Observational Research (2025) Vol. Volume 16, pp. 95-109
Open Access
Severe hypereosinophilia in a patient treated with dupilumab and shift to mepolizumab: the importance of multidisciplinary management. A case report and literature review
Sara Munari, Giulia Ciotti, Walter Cestaro, et al.
Drugs in Context (2024) Vol. 13, pp. 1-11
Open Access | Times Cited: 3
Cardiovascular diseases or type 2 diabetes mellitus and chronic airway diseases: mutual pharmacological interferences
Mario Cazzola, Paola Rogliani, Josuel Ora, et al.
Therapeutic Advances in Chronic Disease (2023) Vol. 14
Open Access | Times Cited: 7
Oral corticosteroid use and sarcopenia-related traits in older people with chronic airway disease: a population-based study
Elizabeth Benz, Lies Lahousse, Johnmary T. Arinze, et al.
ERJ Open Research (2023) Vol. 9, Iss. 5, pp. 00492-2023
Open Access | Times Cited: 6
Gaps in asthma diagnosis and treatment in low- and middle-income countries
Monica Barne
Frontiers in Allergy (2023) Vol. 4
Open Access | Times Cited: 5
Epidemiology of patients with asthma in Korea: Analysis of the NHISS database 2006–2015
Jung‐Hyun Kim, Hyesung Lee, So‐Young Park, et al.
World Allergy Organization Journal (2023) Vol. 16, Iss. 4, pp. 100768-100768
Open Access | Times Cited: 4
Management of asthma in primary care in the changing context of the COVID-19 pandemic: a qualitative longitudinal study with patients
Marta Santillo, Sarah Tonkin‐Crine, Kay Wang, et al.
British Journal of General Practice (2023) Vol. 73, Iss. 737, pp. e903-e914
Open Access | Times Cited: 4
Oral Corticosteroid Abuse and Self-Prescription in Italy: A Perspective from Community Pharmacists and Sales Reports before and during the COVID-19 Era
Emanuele Nappi, Enrico Keber, Giovanni Paoletti, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 5, pp. 833-833
Open Access | Times Cited: 4
A survey of severe asthma in Canada: results from the CASCADE practice reflective program
Krystelle Godbout, Harold Kim, Irvin Mayers, et al.
Allergy Asthma and Clinical Immunology (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 1
A Case in which Eosinophilic Meningoencephalitis Occurred during Oral Corticosteroid Tapering and after Switching from Anti-IL-5 to Anti-IgE Treatment
Yuuya Nishii, Takashi Kinoshita, Jun Sasaki, et al.
Internal Medicine (2024)
Open Access | Times Cited: 1
The Glucocorticoid Taper: A Primer for the Clinicians
Gagan Priya, Bashir Ahmad Laway, Mythili Ayyagari, et al.
Indian Journal of Endocrinology and Metabolism (2024) Vol. 28, Iss. 4, pp. 350-362
Open Access | Times Cited: 1
Modelling Adverse Events in Patients Receiving Chronic Oral Corticosteroids in the UK
Danny Gibson, Neil Branscombe, Neil A. Martin, et al.
PharmacoEconomics - Open (2024) Vol. 8, Iss. 6, pp. 923-934
Open Access | Times Cited: 1
Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences
Mario Cazzola, Clive P. Page, Nicola A. Hanania, et al.
Drugs (2024)
Open Access | Times Cited: 1
Development of an asthma health-care burden score as a measure of severity and predictor of remission in SARP III and U-BIOPRED: results from two major longitudinal asthma cohorts
Joe Zein, Nazanin Zounemat-Kerman, Ian M. Adcock, et al.
The Lancet Respiratory Medicine (2024) Vol. 13, Iss. 1, pp. 35-46
Closed Access | Times Cited: 1
Real-life studies and registries of severe asthma: The advent of digital technology
Veronika Urdova, Linda Rogers, Miloš Jeseňák, et al.
Respiratory Medicine (2023) Vol. 220, pp. 107429-107429
Open Access | Times Cited: 2
Clinical and Economic Burden of Severe Asthma With Low Blood Eosinophil Counts
John Busby, Shruti Menon, Neil Martin, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 10, pp. 2785-2797
Open Access
Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort
Marco Caminati, Alessandro Marcon, Rachele Vaia, et al.
World Allergy Organization Journal (2024) Vol. 17, Iss. 8, pp. 100941-100941
Open Access
Oral and inhaled corticosteroid dose reductions with tezepelumab versus placebo in patients with severe, uncontrolled asthma from DESTINATION
Michael E. Wechsler, Daiana Stolz, Njira Lugogo, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 11, pp. 3128-3131.e2
Open Access
High-CBD Extract (CBD-X) in Asthma Management: Reducing Th2-Driven Cytokine Secretion and Neutrophil/Eosinophil Activity
Miran Aswad, Antonina Pechkovsky, Narmeen Ghanayiem, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1382-1382
Open Access
Page 1 - Next Page

Scroll to top